15 related articles for article (PubMed ID: 15918523)
1. Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases.
Abe F; Alvord G; Koyama M; Matsuda A; Talmadge JE
Cancer Immunol Immunother; 1989; 28(1):29-33. PubMed ID: 2909281
[TBL] [Abstract][Full Text] [Related]
2. HPLC analysis and pharmacokinetic characteristics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, in rats and beagle dogs.
Yoo BI; Ahan KB; Kang MH; Moon DC; Kwon OS; Lee HS; Ryu JS; Kim TY; Song S; Chung YB
Biol Pharm Bull; 2005 Apr; 28(4):688-93. PubMed ID: 15802811
[TBL] [Abstract][Full Text] [Related]
3. High performance liquid chromatographic analysis an pharmacokinetic characteristics of ID-7181, a novel quaternary ammoniopropenyl cephalosporin, following intravenous and intramuscular injections to rats.
Yoo BI; Yeom ZH; Kanga MH; Kwon OS; Kang JH; Yu SW; Moon DC; Song S; Chung YB
Arzneimittelforschung; 2005; 55(9):549-56. PubMed ID: 16229120
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of four metabolites of DA-125, a new anthracycline antineoplastic agent after single and multiple intravenous administration to rats.
Lee SD; Lee WI; Shim HJ; Lee ED; Kim WB; Yang J; Kim CK; Lee MG
J Clin Pharm Ther; 1996 Aug; 21(4):201-13. PubMed ID: 8933293
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
[TBL] [Abstract][Full Text] [Related]
6. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, after i.v. bolus multiple administration in rats.
Yoo BI; Ahan KB; Kang MH; Kwon OS; Hong YS; Lee JJ; Lee HS; Ryu JS; Kim TY; Moon DC; Song S; Chung YB
Arch Pharm Res; 2005 Apr; 28(4):476-82. PubMed ID: 15918523
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
